NCT04572165 2024-01-02Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry DataNovo Nordisk A/SUnknown600,000 enrolled